STAT

JUNE 30, 2023

The five cases of malaria diagnosed in Florida and Texas in recent weeks — the first cases of local transmission in the United States in 20 years — have worried some residents and led state and federal officials to issue public alerts about the cluster of infections. But scientists and public health officials, while advising people in the affected areas to take precautions, say there is little cause for alarm, for several reasons: The number of cases is very low; there are easy, lo

326

326

Pharmacy Is Right For Me

JUNE 30, 2023

Join us as we explore the inspiring journey of Cayden Miller, a passionate pharmacy graduate from Southern Illinois University at Edwardsville School of Pharmacy. Cayden’s experience as a member of the LGBTQIA+ community has shaped his path in pharmacy, driving him to become an advocate for diversity, equity, and inclusion (DEI) within the profession.

246

246

STAT

JUNE 30, 2023

Pat Furlong was sitting in her home office in Middletown, Ohio, last Thursday, refreshing a Food and Drug Administration web page ad nauseam, when the phone rang. She answered and burst into tears. The FDA had just approved the first gene therapy for Duchenne muscular dystrophy, her friend and the therapy’s architect, Jerry Mendell, told her.

280

280

PharmaVoice

JUNE 30, 2023

Vacation is calling, but so are patients. Here's how the industry adjusts in the summer.

255

255

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JUNE 30, 2023

The past several months have been grim for health in the U.S. In December, the Centers for Disease Control and Prevention reported the lowest life expectancy in more than 25 years. Another CDC report in March showed that maternal mortality was on the rise. Yet another report in March found that even children are dying at higher rates than ever before.

238

238

BioPharma Dive

JUNE 30, 2023

The agency granted a long-awaited clearance on Thursday, but unexpected aspects of the hemophilia treatment’s label had some investors worried about its commercial prospects.

Labelling 105

Labelling 105

European Pharmaceutical Review

JUNE 30, 2023

A collaborative approach to advancing adoption of RMMs EPR ’s Caroline Peachey explores collaborative efforts to accelerate validation and adoption of rapid microbial methods across the pharmaceutical industry. The power of rapid methods for fungal ID By leveraging rapid identification techniques, pharmaceutical facilities can enhance their ability to detect and mitigate fungal contamination, safeguarding product quality and patient safety.

105

105

STAT

JUNE 30, 2023

After having a day to read through the Supreme Court’s decision on affirmative action , some medical school and educational leaders are more hopeful that a path exists for them to diversify future classes and the health care workforce as they scramble to understand its impact on the next admissions cycle and the class of 2024. Several told STAT they saw the court’s ruling as explicitly endorsing the use of “holistic review,” a tool used increasingly by medical, dental

Medical Schools 224

Medical Schools 224

Pharmaceutical Technology

JUNE 30, 2023

Health Canada has approved Endo International’s Xcopri as adjunctive therapy in the management of partial-onset seizures in adults with epilepsy.

116

116

STAT

JUNE 30, 2023

In 1983, I flew home from college to be with my mother as she woke up from a mastectomy. She opted out of breast reconstruction, choosing to “go flat” instead. When I was diagnosed with breast cancer in 2017 and had bilateral mastectomies , I had more reconstruction options than my mother did.

223

223

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

BioPharma Dive

JUNE 30, 2023

The life sciences investor spoke with BioPharma Dive about emerging life sciences markets around the globe and why the firm invests in first-time biotech founders.

105

105

STAT

JUNE 30, 2023

In a setback to AIDS activists, a federal court jury on Friday cleared Gilead Sciences and Teva Pharmaceuticals of allegations that the companies struck an illegal deal that inflated prices for HIV medicines. A lawsuit filed four years ago accused Gilead of using a range of controversial business tactics that led the U.S. health care system to overspend for HIV medicines.

180

180

Pharma Times

JUNE 30, 2023

ELATIVE, a randomised PBC trial involving 161 patients, has successfully met its primary endpoint - News - PharmaTimes

118

118

STAT

JUNE 30, 2023

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we expect to mingle with familiar faces, promenade with the official mascots, catch up on our reading, and hold a listening party — the rotation will likely include this , this , this , this and this.

173

173

The Thyroid Pharmacist

JUNE 30, 2023

Have you heard of low dose naltrexone, or LDN? Since the beginning of my Hashimoto’s journey, this medication has been on my radar – and in recent years, I have learned so much more about it. In 2015, I conducted a survey of over 2000 readers with Hashimoto’s , asking for the most helpful interventions in their health journeys. One reader wrote: “Low Dose Naltrexone changed my life for the better.

Compounding 98

Compounding Immunity Immunization Compounding Pharmacies 98

STAT

JUNE 30, 2023

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them.  Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

135

135

Drug Patent Watch

JUNE 30, 2023

Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in three NDAs. It is available from one supplier. There are fifty-five patents… The post New patent for Pharmacyclics Inc drug IMBRUVICA appeared first on DrugPatentWatch - Make Better Decisions.

98

98

BioPharma Dive

JUNE 30, 2023

An agreement to divest the dry eye disease treatment Xiidra and a few other medicines adds to the Swiss pharma's yearslong push to slim down from the healthcare conglomerate it once was.

96

96

European Pharmaceutical Review

JUNE 30, 2023

Demand for process analytical technology ( PAT ) is being driven by the growing adoption of automation and digitalisation in sectors such as pharmaceutical industry, a report by Market.us has found. With PAT being widely used in pharma, rising R&D expenses are anticipated to boost demand for these technologies. Growth and limitations in the global PAT market The PAT market is expected to grow $10.6 billion in 2032, the report suggested.

Compounding 92

Compounding 92

pharmaphorum

JUNE 30, 2023

Editor in Chief Jonah Comstock speaks with Mark Reisenauer, president, US Commercial at Astellas. Mark gives an update on some of Astellas’s abstracts at the show, including the trials in gastric cancer, bladder cancer, and head and neck cancer.

92

92

Pharma Times

JUNE 30, 2023

Partnership will establish drug candidates using both laboratory tests and machine-learning - News - PharmaTimes

107

107

European Pharmaceutical Review

JUNE 30, 2023

The limulus amebocyte lysate (LAL) assay for bacterial endotoxin testing (BET) is currently facing some of its greatest challenges as a reagent in the pharmaceutical industry, according a paper published in the Journal of Applied Bioanalysis. The author highlighted key obstacles and offered potential opportunities for the future. Challenges The first current challenge the author discussed was the supply of materials and conservation of resources for endotoxin testing.

Communication 88

Communication 88

Pharmaceutical Technology

JUNE 30, 2023

BioMed X has announced that it has begun a joint research project with Sanofi on artificial intelligence (AI) driven drug development.

Drug Development 98

Drug Development 98

The Pharmacist

JUNE 30, 2023

Chief executive of the Association of Independent Multiple Pharmacies Dr Leyla Hannbeck writes exclusively for The Pharmacist on her disappointment with the newly published NHS Long Term Workforce Plan Community pharmacy is currently facing the biggest challenges to its workforce and this NHS Long Term Workforce Plan is doing very little to help. In fact, […] The post 'Workforce plan another kick in the teeth for community pharmacy' appeared first on The Pharmacist.

Community Pharmacies 83

Community Pharmacies 83

Pharmaceutical Technology

JUNE 30, 2023

BioMarin’s Roctavian, a one-time therapy for severe haemophilia A, has secured FDA approval following previous rejections and delays.

97

97

World Pharma News

JUNE 30, 2023

A team of researchers led by Dr. Marcus Conrad from Helmholtz Munich discovered a novel anti-cancer drug, called icFSP1, which sensitizes cancer cells to ferroptosis. Ferroptosis is characterized by the iron-dependent oxidative destruction of cellular membranes, which is counteracted by ferroptosis suppressor protein-1 (FSP1), one of the guardians of ferroptosis.

84

84

Express Pharma

JUNE 30, 2023

The app grants young & upcoming post-graduate doctors access to a wealth of medical and non-medical information, equipping them to stay ahead in the rapidly evolving medical landscape This Doctor’s Day, JB Pharma introduced JB NEXT, app exclusively designed for resident doctors & post-graduate medical students. The app is an expression of gratitude to the medical fraternity with its comprehensive and multi-speciality specific content and resources to enhance their knowledge.

Communication 77

Communication 77

The Pharmacist

JUNE 30, 2023

Pharmacists could potentially train as doctors under a shortened medical degree programme which would be available for some existing healthcare professions, while a pharmacist degree apprenticeship is also being considered, NHS England has announced today in its new workforce plan. The Long-Term Workforce Plan also announced that the Additional Roles Reimbursement Scheme (ARRS) will be […] The post Breaking: NHS workforce plan moots apprenticeships and medical training for pharmacists appe

74

74

Big Molecule Watch

JUNE 30, 2023

Beginning tomorrow, July 1, 2023, CYLTEZO® (adalimumab-adbm) will become the first HUMIRA® (adalimumab) biosimilar with interchangeable status to be commercially available in the United States. Boehringer Ingelheim has also announced that with CYLTEZO’s commercial launch, pharmacy-benefit manager Optum Rx (a subsidiary of UnitedHealth Group), which currently covers more than 66 million patients, will place CYLTEZO injection as a preferred brand on its commercial formulary.

Biosimilars 62

Biosimilars 62

The Pharmacist

JUNE 30, 2023

Training places for pharmacists will be expanded by almost a third (29%) by 2028/29, NHS England has announced today within its new workforce plan. And the ambition is to increase training places for the profession by nearly 50% – to around 5,000 places per year – by 2031/32, it said. While the move to increase […] The post Pharmacy training places must be matched by practical experience appeared first on The Pharmacist.

74

74

pharmaphorum

JUNE 30, 2023

UK pilot will seek digital dimension to dementia management Phil.

101

101

The Pharmacist

JUNE 30, 2023

NHS England will seek to extend the Additional Roles Reimbursement Scheme (ARRS) by increasing the number of non-GP direct patient care staff by around 15,000 by 2036/37, it has announced in its workforce plan published today. But it said that the expansion would be ‘carefully managed’, taking into account additional training of pharmacists, to ensure […] The post ARRS to be ‘carefully’ extended appeared first on The Pharmacist.

69

69

pharmaphorum

JUNE 30, 2023

The future, now: Revolutionising disease prevention through predictive genomics Mike.

89

89

Pharmaceutical Technology

JUNE 30, 2023

At DDW 2023, a comment was made following a presentation discussing the preliminary induction findings from the Phase IIb/III QUASAR (NCT04033445) trial in ulcerative colitis (UC).

52

52

pharmaphorum

JUNE 30, 2023

Biomarker study raises hope of better depression therapies Phil.

96

96